Drug release studies of erlotinib hydrochloride loaded formulation
Answers
Answered by
1
Heya!!
Erlotinib-HCl is a quinazoline derivative used as a drug in the therapy of non-small-cell lung cancer. The present study was conducted to compare the subacute toxicity induced by Erlotinib-HCl delivered to rats as nanoparticles and as free drug.
Thanks!
Answered by
0
Explanation:
efficiency, in vitro drug release, and in vitro serum stability. ..... Preparation of half- antibody conjugated ETB-CSLAHNPs . ...... erlotinib hydrochloride loaded albumin nanoparticles
Similar questions